Advanced search
Publication Cover
Leukemia & Lymphoma Volume 15, 1994 - Issue 1-2
Submit an article Journal homepage
30
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Effect of Granulocyte Colony-Stimulating Factor in Patients with Diffuse Large Cell Lymphoma Treated with Intensive Chemotherapy

Agustin Avilés Department of Hematology Oncology Hospital, National Medical Center, Mexico, DF, Mexico
,
Jose C. Díaz-Maqueo Department of Hematology Oncology Hospital, National Medical Center, Mexico, DF, Mexico
,
Alejandra Talavera Department of Hematology Oncology Hospital, National Medical Center, Mexico, DF, Mexico
,
M. Jesús Nambo Department of Hematology Oncology Hospital, National Medical Center, Mexico, DF, Mexico
&
Edna L. García Department of Hematology Oncology Hospital, National Medical Center, Mexico, DF, Mexico
Pages 153-157 | Received 10 Oct 1993, Published online: 01 Jul 2009

References

  • Epelbaum R., Faraggi D., Ben-Arie Y., et al. Survival of diffuse large cell lymphoma. Cancer 1990; 60: 1124–1129
  • Meyer R.M., Hryniuk W.H., Goodyear D.E. The role of dose intensity in determining outcome in intermediate grade non-Hodgkin's lymphoma. J. Clin. Oncol. 1991; 9: 339–342
  • Armitage J.O. The treatment of non-Hodgkin's lymphoma. N. Engl. J. Med. 1993; 328: 1023–1030
  • Gabrilove J.L., Jakubowski A., Scher H., et al. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N. Engl. J. Med. 1988; 318: 1414–1422
  • Morstyn G., Campbell C., Souza L., et al. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1988; 2: 667–672
  • Morstyn G., Campbell C., Lischke G., et al. Treatment of chemotherapy induced neutropenia by subcutaneous administration of granulocyte colony-stimulating factor with optimization of dose and duration of therapy. J. Clin. Oncol. 1989; 7: 1554–1562
  • Bronchud M.H., Howell A., Crowther D., Hopwood P., Souza L., Dexter T.M. The of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast cancer. Br. J. Cancer 1989; 60: 121–125
  • Hougaard D.J., Nissen N.I. Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with Hodgkin's disease. A phase I/II study. J. Clin. Oncol. 1992; 10: 390–397
  • Yoshida T., Najamura S., Ohtake S., et al. Effect of granulocyte colony-stimulating factor on neutropenia due to chemotherapy for non-Hodgkin's lymphoma. Cancer 1990; 66: 1904–1909
  • Biesma B., Valenga E., Willemze P. H. B., De Vries E. G. E. Effect of hematopoietic growth factors on chemotherapy-induced myelosuppression. Crit. Rev. Oncol. Hematol. 1992; 13: 107–134
  • The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphoma. Cancer 1982; 49: 2112–2135
  • Avites A., Dfaz-Maqueo J.C., Rodriguez L., et al. Group-risk classification of non-Hodgkin's lymphoma. Arch. Invest. Med. 1990; 21: 11–16
  • Avites A., Zepeda G., Dfaz-Maqueo J.C., et al. Beta 2 microglobulin level as indicator of prognosis in diffuse large cell lymphoma. Leukemia and Lymphoma 1992; 7: 135–138
  • World Health Organization. “WHO Handbook for reporting results of cancer treatment”. Geneve, Switzerland 1979, WHO Offset Publication No. 48
  • Hryniuk W.H. The importance of dose intensity in the outcome of chemotherapy. Important Advances in Oncology, V.T. DeVita, Jr., S. Hellman, S.A. Rosenberg. J. B. Lippincott, Philadelphia 1988; 121–147
  • De Vita V.T., Jr, Hubbards S.M., Longo D.L. The chemotherapy of lymphomas: Looking back moving forward. Cancer Res. 1987; 47: 5810–5824
  • Klimo P., Connors J.M. Updated clinical experience with MACOP-B. Semin. Oncol. 1987; 24: 26–34
  • Weick J.K., Dahlberg S., Fisher R.I., et al. Combination chemotherapy of intermediate-grade and high-grade non-Hodgkin's lymphoma with MACOP-B. A Southwest Oncology Group Study. J. Clin. Oncol. 1991; 9: 748–753
  • Gaynor R.I., Fisher E.R., Dahlberg S., et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N. Engl. J. Med. 1993; 328: 1002–1006
  • Dodwell D.J., de Campos E.J., Radford J.A. Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. Much is better?. Drugs 1992; 44: 1–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.